A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain

A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain

COVID-19 has emerged, and has rapidly become a major health problem worldwide, causing millions of mortalities. Vaccination against COVID-19 is the most efficient way to stop the pandemic. The goal of vaccines is to induce neutralizing antibodies against SARS-CoV-2 virus. Here, we present a novel do...

Full description

Bibliographic Details
Main Authors: Xinyue Chang, Andris Zeltins, Mona O. Mohsen, Zahra Gharailoo, Lisha Zha, Xuelan Liu, Senta Walton, Monique Vogel, Martin F. Bachmann
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Vaccines
Subjects:
COVID19
SARS-CoV-2
vaccine
virus-like particle
CuMV<sub>TT</sub>-DF
Online Access:https://www.mdpi.com/2076-393X/9/11/1287

Similar Items

Similar Items